# Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites

> **NCT05075876** · PHASE1 · COMPLETED · sponsor: **Solasia Pharma K.K.** · enrollment: 66 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SP-01 manufactured by Site K (SP-01-K, Transdermal patch contained granisetron)
- **DRUG:** SP-01 manufactured by Site A (SP-01-A, Transdermal patch contained granisetron)

## Key facts

- **NCT ID:** NCT05075876
- **Lead sponsor:** Solasia Pharma K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-13
- **Primary completion:** 2021-12-03
- **Final completion:** 2021-12-03
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05075876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05075876, "Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05075876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*